Page last updated: 2024-09-03

ginsenoside rh2 and Inflammation

ginsenoside rh2 has been researched along with Inflammation in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Hu, Y; Lang, Z; Tao, Q; Wang, H; Yu, S; Yu, Z; Zhang, J; Zheng, J; Zheng, L1
Ahn, S; Castro-Aceituno, V; Jiménez-Pérez, ZE; Jung, SK; Kim, YJ; Mathiyalagan, R; Simu, SY; Subramaniyam, S; Wang, C; Yang, DC1
Chen, X; Liu, S; Lv, X; Xu, T; Zhang, J1
Choi, YH; Li, LC; Lin, ZH; Piao, HM; Yan, GH; Zheng, MY1
Bi, WY; Fu, BD; Li, HP; Lv, S; Qin, QQ; Shen, HQ; Song, Z; Wei, Q; Wei, XB; Wu, SC; Yi, PF; Zhang, C1

Other Studies

5 other study(ies) available for ginsenoside rh2 and Inflammation

ArticleYear
Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via regulation of IRF1-inhibited SLC7A11.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2023, Volume: 118

    Topics: Amino Acid Transport System y+; Ferroptosis; Fibrosis; Hepatic Stellate Cells; Humans; Inflammation; Interferon Regulatory Factor-1; Iron; Liver Cirrhosis

2023
Preparation of Polyethylene Glycol-Ginsenoside Rh1 and Rh2 Conjugates and Their Efficacy against Lung Cancer and Inflammation.
    Molecules (Basel, Switzerland), 2019, Nov-29, Volume: 24, Issue:23

    Topics: A549 Cells; Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Drug Delivery Systems; Ginsenosides; Humans; Inflammation; Lung Neoplasms; Macrophages; Mice; Polyethylene Glycols; RAW 264.7 Cells

2019
Ginsenoside Rh2 alleviates ulcerative colitis by regulating the STAT3/miR-214 signaling pathway.
    Journal of ethnopharmacology, 2021, Jun-28, Volume: 274

    Topics: Animals; Anti-Inflammatory Agents; Cell Line; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disease Models, Animal; Ginsenosides; Humans; Inflammation; Male; Mice, Inbred C57BL; MicroRNAs; Signal Transduction; STAT3 Transcription Factor; Sulfasalazine

2021
Ginsenoside Rh2 attenuates allergic airway inflammation by modulating nuclear factor-κB activation in a murine model of asthma.
    Molecular medicine reports, 2015, Volume: 12, Issue:5

    Topics: Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Female; Ginsenosides; Immunoglobulin E; Inflammation; Interleukin-13; Interleukin-4; Interleukin-5; Lung; Mice; Mice, Inbred BALB C; NF-kappa B; Ovalbumin

2015
Sulfated derivative of 20(S)-ginsenoside Rh2 inhibits inflammatory cytokines through MAPKs and NF-kappa B pathways in LPS-induced RAW264.7 macrophages.
    Inflammation, 2012, Volume: 35, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Ginsenosides; Inflammation; Interleukin-10; Interleukin-1beta; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; RNA, Messenger; Sulfates; Transcription Factor RelA; Tumor Necrosis Factor-alpha

2012